Nordwand Advisors, LLC Pro Phase Labs, Inc. Put Options Transaction History
Nordwand Advisors, LLC
- $266 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.42MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA408KShares$126,5620.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA318KShares$98,6190.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny286KShares$88,8100.0% of portfolio
-
Citizens Financial Group Inc270KShares$83,8240.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$71,1300.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.97M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...